dismissals

Setback and Persistence: Zantac Cancer Lawsuits Forge Ahead Despite Federal Dismissals, Trials Continue in Various States

by

Philadelphia – In a recent turn of events in the Zantac litigation saga, Judge Joshua Roberts of the Philadelphia Court of Common Pleas has denied a motion for recusal brought by plaintiffs who pointed to a potential conflict of interest due to his wife’s position at the law firm Reed Smith. The firm represents Zantac manufacturer GlaxoSmithKline in jurisdictions outside of this case, sparking concerns of bias among litigants. The decision came amidst the broader context of numerous Zantac cases alleging that the drug, intended as a heartburn and ulcer remedy, contains unsafe levels of … Read more

Merck Resolves Over 1,000 Zostavax Lawsuits Following Plaintiff Dismissals

by

Rahway, New Jersey — Merck & Co., a leading pharmaceutical company, has reached a significant legal milestone by resolving over a thousand lawsuits connected to its shingles vaccine, Zostavax. The cases were concluded following the plaintiffs’ decision to request dismissals, thus eliminating a batch of longstanding legal grievances against the drugmaker. Zostavax, designed to prevent shingles in older adults, was approved by the U.S. Food and Drug Administration in 2006. Marketed until its production ceased in 2020, it was the only shingles vaccine available in the U.S. for a decade before competitors like Shingrix emerged. … Read more